| SBP | mmHg (β mmHg)* |
|---|---|
| HR | β bpmβ |
| RR | β bpmβ |
| Endotracheal tube (ETT) | |
|---|---|
| Laryngoscope | |
| Uncuffed ETT | |
| Cuffed ETT | |
| Depth at lips | cm |
| Supraglottic airway device (SAD) | |
|---|---|
| LMA | |
| i-Gel | |
| Breathing circuits | |
|---|---|
| T-piece | 0β20 kg |
| Infant (Micro) | 0β10 kg |
| Paediatric (Mini) | 10β30 kg |
| Adult | >20 kg |
| Ventilation | |
|---|---|
| Tidal volume (6β8 ml/kg) | |
| Neonates / ARDS (4β6 ml/kg) | |
| Induction | ||
|---|---|---|
| Fentanyl | 1β2 mcg/kg | mcg |
| Ketamine | 1β2 mg/kg | mg |
| Rocuronium | 1 mg/kg | mg |
| Maintenance infusions | ||
|---|---|---|
| Morphine | 10β40 mcg/kg/h (0.5β2 ml/h) | |
| Midazolam | 1β3 mcg/kg/min (1β3 ml/h) | |
| Propofol | 1β4 mg/kg/h (4β10 mg/kg/h in routine anaesthesia) | |
| Emergency Drugs | ||
|---|---|---|
| Atropine | 20 mcg/kg | mcg |
|
Adrenaline IV 1:10,000 100 mcg/ml |
0.1 mL/kg 10 mcg/kg |
mcg |
| Suxamethonium IV | 1β2 mg/kg | mg |
| Suxamethonium IM |
4 mg/kg (Max 150 mg) |
mg |
| Other | ||
|---|---|---|
| Fluid bolus | 10β20 mL/kg | mL |
| Glucose 10% | 2 mL/kg | mL |
| Defibrillation energy | 4 J/kg | J |
For other drugs and infusions, use Paediatric Emergency Tools: Apple / Android.
| Midazolam - PO | 0.5 mg/kg | mg |
| Max 20 mg per dose; 6 months - 14 years. Peak effect at 20-30 mins. | ||
| Midazolam - NAS | 0.2 mg/kg | mg |
| Max 10 mg. Given via short atomiser: 0.1 ml dead space. Peak effect at 10 mins. | ||
| Dexmedetomidine - NAS | 2β4 mcg/kg | mcg |
| Max 200 mcg per dose. Given 30 mins before intervention. | ||
| Induction | ||
|---|---|---|
| Fentanyl | 1β2 mcg/kg | mcg |
| Propofol | 3β5 mg/kg | mg |
| Rocuronium | 0.6 mg/kg | mg |
| Antiemetics | ||
|---|---|---|
| Dexamethasone | 0.15 mg/kg | mg |
| Ondansetron | 0.15 mg/kg | mg |
| Cyclizine | 0.5β1 mg/kg | mg |
| Intraoperative analgesia | ||
|---|---|---|
| Paracetamol IV | mg | |
| Ibuprofen IV | 5β10 mg/kg | mg |
| Ketorolac IV | 0.5β1 mg/kg | mg |
| Diclofenac IV | 1 mg/kg | mg |
| Morphine IV | 0.05β0.1 mg/kg | mg |
| Reversal of neuromuscular blockade | ||
|---|---|---|
|
Neostigmine & Glycopyrulate 2.5 mg/1mL & 500 mcg/1 mL |
0.02 mL/kg 0.05 mg/kg & 10 mcg/kg | ml |
| Sugammadex | 2 mg/kg | mg |
|
Moderate block: Return of T2 in response to TOF. |
||
| Sugammadex | 4 mg/kg | mg |
|
Deep block: 1-2 PTCs, no twitch responses to TOF. |
||
| Postoperative analgesia | ||
|---|---|---|
| Paracetamol PO | mg | |
| Ibuprofen PO | 5β10 mg/kg | mg |
| Morphine PO | mg | |
| Emergency Drugs | ||
|---|---|---|
| Atropine | 20 mcg/kg | mcg |
| Suxamethonium IV | 1β2 mg/kg | mg |
| Suxamethonium IM |
4 mg/kg (Max 150 mg) |
mg |
| Amoxicillin | 30 mg/kg (Max 1 g) | mg |
| Cefuroxime | 50 mg/kg (Max 1.5g) | mg |
| Co-Amoxiclav | 30 mg/kg (Max 1.2 g) | mg |
| Flucloxacillin (Soft tissue) | 25 mg/kg (Max 1 g) | mg |
| Flucloxacillin (Open orthopaedic surgery) | 50 mg/kg (Max 2 g) | mg |
| Metronidazole | 30 mg/kg (Max 500 mg) | mg |
| Teicoplanin | mg | |
| Gentamicin | 2.5 mg/kg (Max 160 mg) | mg |
| In obesity doses should be calculated based on adjusted body weight. | ||
| Gentamicin (high-dose) | 5 mg/kg (Max 480 mg) | mg |
| In obesity doses should be calculated based on adjusted body weight. | ||
| Arterial lines - Radial | |
|---|---|
| Neonates/Infants <10 kg |
24 G Pressure transducer: 150 mmHg (generates a flow rate of 1.5 mL/hr) |
| Children >10 kg |
22 G Pressure transducer: 300 mmHg (generates a flow rate of 3 mL/hr) |
| Children >50 kg | 20 G |
| Arterial lines - Femoral | |
|---|---|
| Neonates | 22 G, 8cm |
| Children | 20 G, 8cm |
| Central venous access - Femoral (preferred) | |
|---|---|
| <6 months | 4β5 Fr, triple lumen, 6β8cm lines |
| 6 mβ5 y | 5 Fr triple lumen, 8β12 cm |
| >5 y | 7 fr, triple lumen, 15 cm |
| Central venous access - Internal jugular | |
|---|---|
| <15 kg | 5 cm |
| 16β40 kg | 8 cm |
| >40 kg | 13 cm |
| EZ-IO | |
|---|---|
| <--- | --- |
| --- | --- |
| >--- | --- |
| Suction catheters | |
|---|---|
| <--- | --- |
| --- | --- |
| >--- | --- |
| Weight (kg) | |
|---|---|
| Age 1-12 months |
0.5 x Age (months) + 4 |
| Age 1-5 years |
2 x Age (years) + 8 |
| Age 6-14 years |
2 x Age (years) + 8 3 x Age (years) + 7 |
| Airway and Ventilation | |
|---|---|
| ETT size |
Uncuffed ETT size = (Age/4) + 4 [Cole formula] Cuffed ETT size = (Age/4) + 3.5 [Modified Cole] |
| ETT depth (oral) |
Above 1 year: Depth β Age/2+12 Neonates: Depth β 1.17 Γ Birth weight (kg) + 5.58 (Tochen / β7-8-9β rule) |
| ETT depth (nasal) |
Above 1 year: Depth β Age/2+15 |
| Circulation | |
|---|---|
| Lowest acceptable SBP |
<1 month: ≥60 mmHg 1 month to 1 year: ≥70 mmHg 1β10 years: 2 x Age + 70 mmHg |
| Lowest acceptable MAP |
Age (in years) x 1.5 + 40 mmHg |
| Premature Neonates |
Gestational age β Mean Arterial Pressure |